<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Clinical and Basic Research</title>
<title_fa>Journal of Clinical and Basic Research</title_fa>
<short_title>jcbr</short_title>
<subject>Medical Sciences</subject>
<web_url>http://jcbr.goums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2538-3736</journal_id_issn>
<journal_id_issn_online>2538-3736</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61186/jcbr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1402</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2023</year>
	<month>9</month>
	<day>1</day>
</pubdate>
<volume>7</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Using the Papanicolaou (Pap) smear for cervical cancer screening in a tertiary care hospital: a prospective study and clinical correlation</title>
	<subject_fa>زنان و زایمان</subject_fa>
	<subject>Obstetrics and Gynecology</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;span style=&quot;font-size:12px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;b&gt;Background:&lt;/b&gt; Cervical cancer is the most frequent cause of death for women in developing countries. India, the second-most populous nation in the world, accounts for about 25% of cervical cancer deaths. Even in its premalignant stage, cervical cancer can be detected using a Papanicolaou (Pap) smear test.&lt;br&gt;
The goal was to study the role of Pap smear in detecting premalignant, malignant, and non-neoplastic lesions of the cervix and to ascertain the frequency of different lesions.&lt;br&gt;
&lt;b&gt;Methods:&lt;/b&gt; All women who visited the obstetrics and gynecology outpatient department (OPD) at GMERS Medical College and Hospital, Navsari, India, in 1 year for different clinical problems were recruited. A total of 322 women who were sexually active and over 21 years of age were enrolled in the study. A Pap smear was used for all the women to screen for cervical cancer. The smear was obtained using an Ayre spatula and spread over a marked glass slide, which was placed in 95% ethyl alcohol and sent to the Department of Pathology for cytopathological examination. Women who had visible malignant cervical lesions were excluded. All the data were recorded in a predetermined form.&lt;br&gt;
&lt;b&gt;Results:&lt;/b&gt; A total of 322 patients were screened. Out of 322, 261 smears were NILM (negative for intraepithelial lesion or malignancy) and 126 (39.1 %) smears had inflammatory changes; 2.2 % and 1.2% smears showed changes as ASCUS (atypical squamous cells of undetermined significance) and ASC-H (atypical squamous cells cannot exclude high-grade squamous intraepithelial lesions), respectively; 4.7 % and 5.3% smears showed LSIL (low-grade squamous intraepithelial lesion) and HSIL (high-grade squamous intraepithelial lesion). Squamous cell carcinoma was observed in only 2 (0.6%) of the smears. A total of 16 (4.9%) smears were unsatisfactory for evaluation because they lacked sufficient squamous components or were obscured by inflammation.&lt;br&gt;
&lt;b&gt;Conclusion&lt;/b&gt;: The Pap smear test is a very easy, non-invasive, useful, simple, safe, and economical tool to detect preinvasive cervical epithelial lesions. It is evident and proven that every woman above the age of 30&amp;ndash;35 years must be subjected to cervical screening, and this must be continued even in the postmenopausal period.&lt;/span&gt;&lt;/span&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Uterine cervical neoplasms,Cytology,Papanicolaou test</keyword>
	<start_page>26</start_page>
	<end_page>29</end_page>
	<web_url>http://jcbr.goums.ac.ir/browse.php?a_code=A-10-452-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Devangkumar</first_name>
	<middle_name></middle_name>
	<last_name>Patel</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>devdev966@gmail.com</email>
	<code>10031947532846004882</code>
	<orcid>0009-0005-1496-8842</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department, GMERS Medical College, Panchmahal, Gujarat, India</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Sameer</first_name>
	<middle_name></middle_name>
	<last_name>Kadam</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846004883</code>
	<orcid>0009-0005-1346-0234</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department, VIMS, Palghar, Maharastra, India</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ankita</first_name>
	<middle_name></middle_name>
	<last_name>Patel</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846004884</code>
	<orcid>0009-0000-1291-0616</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Navsari, Gujarat, India</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
